Ginés Escolar

8PUBLICATIONS
36CO-AUTHORS
Major global burdens of diseaseAllergyHaematologyHaematological tumoursBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 13, 2026
Common Biomarkers of Endothelial Dysfunction Across Highly Prevalent Diseases with Cardiovascular Risk: Functional Characterization and Prognostic Implications.

|Apr 28, 2026
Endothelial activation and damage associated with steroid-refractory aGVHD are counteracted by ruxolitinib.

|Mar 07, 2025
Cost-effectiveness and cost-utility analysis of Haemate-P versus other von Willebrand disease treatments in Spain.

Juan E Megias-Vericat, Gines Escolar, Michele R Wilson

|Feb 10, 2025
Plasma-Derived von Willebrand Factor/Factor VIII Concentrate (Haemate P) in von Willebrand Disease: A Systematic Review and Pharmacovigilance Update.

Carmen Escuriola Ettingshausen, Riitta Lassila, Gines Escolar

|Dec 18, 2024
Cost-effectiveness of Voncento prophylaxis vs on-demand treatment in von Willebrand disease in the United Kingdom.

Michele Wilson, Giancarlo Castaman, Will Thomas

|Jan 13, 2023
Mafosfamide, a cyclophosphamide analog, causes a proinflammatory response and increased permeability on endothelial cells in vitro.

Julia Martinez-Sanchez, Roger Pascual-Diaz, Marta Palomo

Pageof 2

Frequent Collaborators

3 joint publications

Maribel Diaz-Ricart

2 joint publications

Ana Belén Moreno-Castaño

2 joint publications

Julia Martinez-Sanchez

1 joint publications

Marta Palomo